TrialBreast cancer research and treatment2024

Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens.

Azadeh Nasrazadani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.